Compounds > methamphetamine

methamphetamine and cyclic gmp

methamphetamine has been researched along with cyclic gmp in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's5 (62.50)18.2507
2000's0 (0.00)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cler, JA; Iyengar, S; Mick, SJ; Rao, TS; Wood, PL2
Cler, JA; Contreras, PC; Emmett, MR; Iyengar, S; Mick, SJ; Rao, TS; Wood, PL1
Cler, JA; Contreras, PC; Dilworth, VM; Emmett, MR; Gray, NM; Iyengar, S; Mick, SJ; Rao, TS; Wood, PL1
Cler, JA; Contreras, PC; Iyengar, S; Lanthorn, TH; Mick, SJ; Ragan, DM; Rao, TS; Wood, PL1
Kageyama, H; Kurosawa, A1
Angulo, JA; Yarosh, HL1
Harada, A; Kimura, H; Miyamoto, M; Suzuki, H; Suzuki, K1

Other Studies

8 other study(ies) available for methamphetamine and cyclic gmp

ArticleYear
Polyamines modulate events mediated by the N-methyl-D-aspartate (NMDA) receptor complex through an ifenprodil-insensitive pathway: in vivo measurements of cyclic GMP in the cerebellum.
    Neuropharmacology, 1991, Volume: 30, Issue:6

    Topics: Animals; Biogenic Polyamines; Cerebellum; Cyclic GMP; Dizocilpine Maleate; Injections, Intraventricular; Male; Methamphetamine; Mice; Neural Pathways; Ornithine; Pentylenetetrazole; Piperidines; Putrescine; Receptors, N-Methyl-D-Aspartate; Spermidine; Spermine

1991
Clozapine attenuates N-methyl-D-aspartate receptor complex-mediated responses in vivo: tentative evidence for a functional modulation by a noradrenergic mechanism.
    Neuropharmacology, 1991, Volume: 30, Issue:6

    Topics: Adrenergic alpha-Antagonists; Animals; Cerebellum; Clozapine; Cyclic GMP; Dioxanes; Haloperidol; Harmaline; Histamine H2 Antagonists; In Vitro Techniques; Indoles; Injections, Intraventricular; Male; Methamphetamine; Mice; Norepinephrine; Pentylenetetrazole; Receptors, N-Methyl-D-Aspartate; Ritanserin; Serine; Tropisetron

1991
Effects of sigma ligands on mouse cerebellar cyclic guanosine monophosphate (cGMP) levels in vivo: further evidence for a functional modulation of N-methyl-D-aspartate (NMDA) receptor complex-mediated events by sigma ligands.
    Brain research, 1991, Oct-04, Volume: 561, Issue:1

    Topics: Animals; Cerebellum; Cyclic GMP; Dopamine Agents; Harmaline; Ligands; Male; Methamphetamine; Mice; Pentylenetetrazole; Piperidines; Quisqualic Acid; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid; Receptors, sigma; Serine

1991
Opipramol, a potent sigma ligand, is an anti-ischemic agent: neurochemical evidence for an interaction with the N-methyl-D-aspartate receptor complex in vivo by cerebellar cGMP measurements.
    Neuropharmacology, 1990, Volume: 29, Issue:12

    Topics: Animals; Cerebellum; Cyclic GMP; Gerbillinae; Hippocampus; Ischemic Attack, Transient; Ligands; Male; Methamphetamine; Mice; Neurons; Opipramol; Pentylenetetrazole; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid; Receptors, sigma

1990
Inhibition of climbing and mossy fiber, and basket and stellate cell inputs to mouse cerebellar Purkinje cells by novel anti-ischemic agents, ifenprodil and BMY-14802.
    Life sciences, 1990, Volume: 47, Issue:1

    Topics: Analysis of Variance; Animals; Cyclic GMP; Harmaline; Male; Methamphetamine; Mice; Mice, Inbred Strains; Neurons; Pentylenetetrazole; Piperazines; Piperidines; Purkinje Cells; Pyrimidines; Radioimmunoassay; Receptors, Amino Acid; Receptors, Cell Surface

1990
Long-lasting inhibitory action of caerulein on climbing fiber system in the cerebellum of the rat.
    Neuropharmacology, 1989, Volume: 28, Issue:9

    Topics: Animals; Apomorphine; Cerebellum; Ceruletide; Cyclic GMP; Drug Interactions; Harmaline; Injections, Intraperitoneal; Male; Methamphetamine; Picrotoxin; Rats; Rats, Inbred Strains; Vagotomy

1989
Modulation of methamphetamine-induced nitric oxide production by neuropeptide Y in the murine striatum.
    Brain research, 2012, Nov-05, Volume: 1483

    Topics: Analysis of Variance; Animals; Arginine; Caspase 3; Corpus Striatum; Cyclic GMP; Drug Interactions; Male; Methamphetamine; Mice; Mice, Inbred ICR; Microinjections; Neuropeptide Y; Nitric Oxide Synthase Type II; Peptides; Protein Precursors; Receptors, Neuropeptide Y; RNA, Messenger; Tyrosine

2012
TAK-063, a PDE10A Inhibitor with Balanced Activation of Direct and Indirect Pathways, Provides Potent Antipsychotic-Like Effects in Multiple Paradigms.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2016, Volume: 41, Issue:9

    Topics: Animals; Antipsychotic Agents; Brain; Corpus Striatum; Cyclic AMP; Cyclic GMP; Dizocilpine Maleate; Dopamine; Dose-Response Relationship, Drug; Hyperkinesis; Male; Methamphetamine; Mice, Inbred C57BL; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Prepulse Inhibition; Pyrazoles; Pyridazines; Quinolines; Rats, Sprague-Dawley

2016